Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist
Who Might Benefit: The 6.6 Million Estimate A Yale team analyzed national registries to mirror SELECT trial eligibility and estimated that about 6.6 million Americans have obesity or overweight and established cardiovascular disease, but not diabetes
off-label use for weight management Prescribers in WA / MDs, DOs, NPs (independent practice), PAs (collaborative agreement) Telehealth prescribing / legal in Washington for scheduled and non-scheduled Rx Washington Medicaid / covered for type 2 diabetes with prior authorization 503A compounding / permitted
Free Assessment Quiz : To find out if you qualify for our prescription weight loss medications, we encourage you to take our free assessment quiz
The image represents the mechanism of action of Tirzepatide
US$ 24.47
US$ 24.09
US$ 29.29
US$ 20.76
US$ 22.44
US$ 24.71
